ZTS

#421
Zoetis Inc. Class A Common Stock
77.7 6 USD
-0.65%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
77.44
78.38
Intervallo Annuale
0.78
147.90
Variazione giornaliera
-0.65%
Variazione Mensile
-31.94%
Variazione di 6 mesi
-39.39%
Variazione Annuale
-46.86%
Chiusura Precedente
78.2 7
Open
78.1 6
Minimo
77.4 4
High
78.3 8
Volume
1 158
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 32.6 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
19.38
Rapporto prezzo/fatturato
5.44
Dividendi per azione
0.53
Rendimento da dividendi %
2.59

Zoetis Inc. Class A Common Stock

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Notizie